BioSpecifics Technologies (BSTC) Looks Good: Stock Moves 9.5% Higher

BioSpecifics Technologies Corp. (BSTC) was a big mover last session, as the company saw its shares rise by over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up more than 19% in the past one-month time frame.

In the past 30 days, this biopharmaceutical company has seen one positive estimate revision and its Zacks Consensus Estimate has moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock, going forward, to see if the recent rise translates into more strength down the road.

BioSpecifics currently has a Zacks Rank #1 (Strong Buy) and its Earnings ESP is 0.00%.

Some other stocks in the same industry worth considering include Lannett Company, Inc. (LCI), Furiex Pharmaceuticals, Inc. (FURX) and Jazz Pharmaceuticals Public Limited Company (JAZZ). All these stocks carry the same Zacks Rank as BioSpecifics.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


BIOSPECIFICS TECH CORP (BSTC): Free Stock Analysis Report

LANNETT CO INC (LCI): Free Stock Analysis Report

JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report

FURIEX PHARMACEUTICALS INC (FURX): Free Stock Analysis Report


Zacks Investment Research